Abstract: The present invention relates in part protective groups that can be used to reversibly protect benzoxaboroles and yield the corresponding protected complexes. The invention further relates to the use of these protective groups to protect benzoxaboroles.

Abstract: The present invention relates to the unexpected discovery of a novel yeast culture medium comprising a concentration of cupric sulfate sufficient to promote growth of strains of Saccharomyces cerevisiae var. diastaticus while inhibiting growth of other varieties of brewing yeast. In certain embodiments, the invention provides a yeast culture medium. In other embodiments, the invention provides methods of using the novel yeast culture medium to test yeast slurries for contamination with Saccharomyces cerevisiae var. diastaticus.

Abstract: The present invention relates in part to the discovery that benzodiazepines can be used to reactivate latent HIV-1 virus that is integrated into human genome. In other embodiments, the benzodiazepine is used in combination with a histone deacetylase inhibitor (HDACi), such as but not limited to SAHA (also known as N-hydroxy-N-phenyl-octanediamide, Suberoylanilide hydroxamic acid, Vorinostat). In yet other embodiments, the combination of benzodiazepine and the HDACi synergistically reactivates latent HIV-1 virus that is integrated into human genome, with minimal or no significant toxicity associated with the dose of either agent.